East Hanover, N.J., June 30, 2022 — Novartis today announced that it has acquired Kedalion Therapeutics and its AcuStream™ technology, an innovative device that may have the potential to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications to the eye. FLG client, Kedalion Therapeutics, is a clinical-stage,…Read More
Hustle engaged FLG when we started scaling rapidly after our Series B. Patty Fukami joined our team and seemingly overnight leveled up our entire Finance operation, including accounting, billing, and FP&A. Beyond that, she has been a true partner to me as CEO in growing the business and has become a highly respected leader at the company, shifting Hustle’s entire culture to be more financially prudent and to make better decisions for the long-term financial health of the business.
Roddy Lindsay, CEO and Co-founder, Hustle Read More